HEADER OXIDOREDUCTASE 14-FEB-10 3LT1 TITLE ENOYL-ACP REDUCTASE FROM PLASMODIUM FALCIPARUM (PFENR) IN COMPLEX WITH TITLE 2 TRICLOSAN VARIANT T2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACP REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 96-424; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 5833; SOURCE 4 GENE: FABI; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28A(+)(NOVAGEN) KEYWDS TRICLOSAN, TRICLOSAN VARIANT, ENOYL-ACP REDUCTASE, OXIDOREDUCTASE, KEYWDS 2 P.FALCIPARUM EXPDTA X-RAY DIFFRACTION AUTHOR K.MAITY,S.P.BHARGAV,B.SANKARAN,N.SUROLIA,A.SUROLIA,K.SUGUNA REVDAT 2 01-NOV-23 3LT1 1 REMARK REVDAT 1 16-JUN-10 3LT1 0 JRNL AUTH K.MAITY,S.P.BHARGAV,B.SANKARAN,N.SUROLIA,A.SUROLIA,K.SUGUNA JRNL TITL X-RAY CRYSTALLOGRAPHIC ANALYSIS OF THE COMPLEXES OF ENOYL JRNL TITL 2 ACYL CARRIER PROTEIN REDUCTASE OF PLASMODIUM FALCIPARUM WITH JRNL TITL 3 TRICLOSAN VARIANTS TO ELUCIDATE THE IMPORTANCE OF DIFFERENT JRNL TITL 4 FUNCTIONAL GROUPS IN ENZYME INHIBITION JRNL REF IUBMB LIFE V. 62 467 2010 JRNL REFN ISSN 1521-6543 JRNL PMID 20503440 JRNL DOI 10.1002/IUB.327 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0044 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 35382 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1859 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2576 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 121 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4404 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 382 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : 0.18000 REMARK 3 B33 (A**2) : -0.36000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.228 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.188 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.388 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4676 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6355 ; 1.589 ; 1.992 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 587 ; 5.254 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 190 ;40.201 ;24.526 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 769 ;15.346 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;22.147 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 712 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3489 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2880 ; 1.006 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4606 ; 1.858 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1796 ; 2.645 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1744 ; 4.223 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3LT1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1000057693. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9774 REMARK 200 MONOCHROMATOR : HORIZONTALLY FOCUSSING REMARK 200 ASYMMETRIC-CUT SINGLE BOUNCE REMARK 200 SI(220) BENT CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : VERTICALLY FOCUSING RHPT COATED REMARK 200 MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37309 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 47.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.60 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 8.30 REMARK 200 R MERGE FOR SHELL (I) : 0.72900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1UH5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.8-3M AMMONIUM SULPHATE, 0.1M MES REMARK 280 BUFFER, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.49100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 65.55350 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 65.55350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.23650 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 65.55350 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 65.55350 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.74550 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 65.55350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.55350 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.23650 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 65.55350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.55350 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.74550 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.49100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -97.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 131.10700 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 131.10700 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.49100 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 326 REMARK 465 ASN A 327 REMARK 465 ASN A 328 REMARK 465 THR A 329 REMARK 465 TYR A 330 REMARK 465 GLU A 331 REMARK 465 ASN A 332 REMARK 465 ASN A 333 REMARK 465 THR A 334 REMARK 465 ASN A 335 REMARK 465 GLN A 336 REMARK 465 ASN A 337 REMARK 465 LYS A 338 REMARK 465 ASN A 339 REMARK 465 ARG A 340 REMARK 465 ASN A 341 REMARK 465 ARG A 342 REMARK 465 HIS A 343 REMARK 465 ASP A 344 REMARK 465 VAL A 345 REMARK 465 HIS A 346 REMARK 465 ASN A 347 REMARK 465 ILE A 348 REMARK 465 MET A 349 REMARK 465 ASN A 350 REMARK 465 ASN A 351 REMARK 465 SER A 352 REMARK 465 GLY A 353 REMARK 465 GLU A 354 REMARK 465 LYS A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 LYS A 358 REMARK 465 LYS A 359 REMARK 465 ILE A 360 REMARK 465 SER A 361 REMARK 465 ALA A 362 REMARK 465 SER A 363 REMARK 465 GLN A 364 REMARK 465 ASN A 365 REMARK 465 TYR A 366 REMARK 465 ASN B 327 REMARK 465 ASN B 328 REMARK 465 THR B 329 REMARK 465 TYR B 330 REMARK 465 GLU B 331 REMARK 465 ASN B 332 REMARK 465 ASN B 333 REMARK 465 THR B 334 REMARK 465 ASN B 335 REMARK 465 GLN B 336 REMARK 465 ASN B 337 REMARK 465 LYS B 338 REMARK 465 ASN B 339 REMARK 465 ARG B 340 REMARK 465 ASN B 341 REMARK 465 ARG B 342 REMARK 465 HIS B 343 REMARK 465 ASP B 344 REMARK 465 VAL B 345 REMARK 465 HIS B 346 REMARK 465 ASN B 347 REMARK 465 ILE B 348 REMARK 465 MET B 349 REMARK 465 ASN B 350 REMARK 465 ASN B 351 REMARK 465 SER B 352 REMARK 465 GLY B 353 REMARK 465 GLU B 354 REMARK 465 LYS B 355 REMARK 465 GLU B 356 REMARK 465 GLU B 357 REMARK 465 LYS B 358 REMARK 465 LYS B 359 REMARK 465 ILE B 360 REMARK 465 SER B 361 REMARK 465 ALA B 362 REMARK 465 SER B 363 REMARK 465 GLN B 364 REMARK 465 ASN B 365 REMARK 465 TYR B 366 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 96 CG OD1 ND2 REMARK 470 GLU A 97 CB CG CD OE1 OE2 REMARK 470 LYS A 143 CG CD CE NZ REMARK 470 LYS A 146 CG CD CE NZ REMARK 470 LYS A 155 CG CD CE NZ REMARK 470 ASP A 156 CB CG OD1 OD2 REMARK 470 LYS A 157 CG CD CE NZ REMARK 470 ASN A 160 CG OD1 ND2 REMARK 470 GLU A 179 CB CG CD OE1 OE2 REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 LYS A 182 CG CD CE NZ REMARK 470 ASN A 183 CG OD1 ND2 REMARK 470 LYS A 185 CG CD CE NZ REMARK 470 ARG A 186 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 188 CG OD1 ND2 REMARK 470 LYS A 232 CG CD CE NZ REMARK 470 ASN A 302 CG OD1 ND2 REMARK 470 LYS A 325 CB CG CD CE NZ REMARK 470 GLU A 374 CG CD OE1 OE2 REMARK 470 ASN B 96 CG OD1 ND2 REMARK 470 GLU B 97 CB CG CD OE1 OE2 REMARK 470 LYS B 140 CG CD CE NZ REMARK 470 LYS B 146 CG CD CE NZ REMARK 470 ASN B 149 CG OD1 ND2 REMARK 470 ASP B 154 CG OD1 OD2 REMARK 470 LYS B 155 CG CD CE NZ REMARK 470 ASP B 156 CB CG OD1 OD2 REMARK 470 LYS B 157 CG CD CE NZ REMARK 470 LYS B 158 CG CD CE NZ REMARK 470 ASN B 160 CG OD1 ND2 REMARK 470 MET B 189 CB CG SD CE REMARK 470 GLN B 191 CG CD OE1 NE2 REMARK 470 GLN B 204 CG CD OE1 NE2 REMARK 470 LYS B 232 CG CD CE NZ REMARK 470 ARG B 318 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 324 CG OD1 ND2 REMARK 470 LYS B 325 CB CG CD CE NZ REMARK 470 LEU B 326 CG CD1 CD2 REMARK 470 GLU B 374 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 107 -162.60 -171.57 REMARK 500 ASN A 144 3.97 -69.35 REMARK 500 ASP A 154 -164.51 173.90 REMARK 500 ALA A 219 109.36 -165.05 REMARK 500 ARG A 383 79.53 -101.27 REMARK 500 ASP A 414 25.03 -148.23 REMARK 500 PHE A 421 -69.15 -102.67 REMARK 500 ASP B 107 -165.10 -172.87 REMARK 500 ILE B 153 -85.21 -100.34 REMARK 500 LYS B 155 -11.65 72.30 REMARK 500 ALA B 219 113.87 -163.88 REMARK 500 ARG B 404 -47.34 -27.93 REMARK 500 ASP B 414 30.28 -151.79 REMARK 500 PHE B 421 -71.74 -101.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FT2 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FT2 B 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UH5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ENOYL-ACP REDUCTASE WITH TRICLOSAN AT REMARK 900 2.2ANGSTROMS REMARK 900 RELATED ID: 1V35 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EOYL-ACP REDUCTASE WITH NADH REMARK 900 RELATED ID: 2OOS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ENOYL ACP REDUCTASE WITH REMARK 900 TRICLOSAN REDUCTASE REMARK 900 RELATED ID: 2OL4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ENOYL ACP REDUCTASE WITH REMARK 900 TRICLOSAN REDUCTASE REMARK 900 RELATED ID: 1ZXL RELATED DB: PDB REMARK 900 SYNTHESIS, BIOLOGICAL ACTIVITY, AND X-RAY CRYSTAL STRUCTURAL REMARK 900 ANALYSIS OF DIARYL ETHER INHIBITORS OF MALARIAL ENOYL ACP REMARK 900 REDUCTASE. PART 1:4'-SUBSTITUTED TRICLOSAN DERIVATIVES REMARK 900 RELATED ID: 1ZSN RELATED DB: PDB REMARK 900 SYNTHESIS, BIOLOGICAL ACTIVITY, AND X-RAY CRYSTAL STRUCTURAL REMARK 900 ANALYSIS OF DIARYL ETHER INHIBITORS OF MALARIAL ENOYL ACP REMARK 900 REDUCTASE. PART 1:4'-SUBSTITUTED TRICLOSAN DERIVATIVES REMARK 900 RELATED ID: 3LSY RELATED DB: PDB REMARK 900 RELATED ID: 3LT0 RELATED DB: PDB REMARK 900 RELATED ID: 3LT2 RELATED DB: PDB REMARK 900 RELATED ID: 3LT4 RELATED DB: PDB DBREF 3LT1 A 96 424 UNP Q9BJJ9 Q9BJJ9_PLAFA 96 424 DBREF 3LT1 B 96 424 UNP Q9BJJ9 Q9BJJ9_PLAFA 96 424 SEQRES 1 A 329 ASN GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR SEQRES 2 A 329 ASN GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS SEQRES 3 A 329 ARG ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL SEQRES 4 A 329 TYR ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE SEQRES 5 A 329 ASP ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN SEQRES 6 A 329 ILE LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR SEQRES 7 A 329 ALA ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG SEQRES 8 A 329 TYR ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA SEQRES 9 A 329 ASN LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU SEQRES 10 A 329 VAL HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP SEQRES 11 A 329 LEU LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SEQRES 12 A 329 SER LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR SEQRES 13 A 329 PHE VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER SEQRES 14 A 329 LEU THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR SEQRES 15 A 329 GLY GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER SEQRES 16 A 329 ASP THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR SEQRES 17 A 329 ASN ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SEQRES 18 A 329 SER ARG ALA ALA THR ALA ILE ASN LYS LEU ASN ASN THR SEQRES 19 A 329 TYR GLU ASN ASN THR ASN GLN ASN LYS ASN ARG ASN ARG SEQRES 20 A 329 HIS ASP VAL HIS ASN ILE MET ASN ASN SER GLY GLU LYS SEQRES 21 A 329 GLU GLU LYS LYS ILE SER ALA SER GLN ASN TYR THR PHE SEQRES 22 A 329 ILE ASP TYR ALA ILE GLU TYR SER GLU LYS TYR ALA PRO SEQRES 23 A 329 LEU ARG GLN LYS LEU LEU SER THR ASP ILE GLY SER VAL SEQRES 24 A 329 ALA SER PHE LEU LEU SER ARG GLU SER ARG ALA ILE THR SEQRES 25 A 329 GLY GLN THR ILE TYR VAL ASP ASN GLY LEU ASN ILE MET SEQRES 26 A 329 PHE LEU PRO ASP SEQRES 1 B 329 ASN GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR SEQRES 2 B 329 ASN GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS SEQRES 3 B 329 ARG ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL SEQRES 4 B 329 TYR ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE SEQRES 5 B 329 ASP ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN SEQRES 6 B 329 ILE LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR SEQRES 7 B 329 ALA ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG SEQRES 8 B 329 TYR ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA SEQRES 9 B 329 ASN LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU SEQRES 10 B 329 VAL HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP SEQRES 11 B 329 LEU LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SEQRES 12 B 329 SER LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR SEQRES 13 B 329 PHE VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER SEQRES 14 B 329 LEU THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR SEQRES 15 B 329 GLY GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER SEQRES 16 B 329 ASP THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR SEQRES 17 B 329 ASN ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SEQRES 18 B 329 SER ARG ALA ALA THR ALA ILE ASN LYS LEU ASN ASN THR SEQRES 19 B 329 TYR GLU ASN ASN THR ASN GLN ASN LYS ASN ARG ASN ARG SEQRES 20 B 329 HIS ASP VAL HIS ASN ILE MET ASN ASN SER GLY GLU LYS SEQRES 21 B 329 GLU GLU LYS LYS ILE SER ALA SER GLN ASN TYR THR PHE SEQRES 22 B 329 ILE ASP TYR ALA ILE GLU TYR SER GLU LYS TYR ALA PRO SEQRES 23 B 329 LEU ARG GLN LYS LEU LEU SER THR ASP ILE GLY SER VAL SEQRES 24 B 329 ALA SER PHE LEU LEU SER ARG GLU SER ARG ALA ILE THR SEQRES 25 B 329 GLY GLN THR ILE TYR VAL ASP ASN GLY LEU ASN ILE MET SEQRES 26 B 329 PHE LEU PRO ASP HET NAD A 501 44 HET FT2 A 502 18 HET NAD B 601 44 HET FT2 B 602 18 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM FT2 5-(CHLOROMETHYL)-2-(2,4-DICHLOROPHENOXY)PHENOL FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 FT2 2(C13 H9 CL3 O2) FORMUL 7 HOH *382(H2 O) HELIX 1 1 GLY A 110 ARG A 122 1 13 HELIX 2 2 TRP A 131 ASN A 144 1 14 HELIX 3 3 ASP A 148 ILE A 152 5 5 HELIX 4 4 THR A 173 ILE A 177 5 5 HELIX 5 5 ASP A 178 ASN A 183 1 6 HELIX 6 6 ASN A 184 MET A 189 1 6 HELIX 7 7 THR A 194 GLY A 207 1 14 HELIX 8 8 ASP A 225 THR A 229 5 5 HELIX 9 9 SER A 230 SER A 242 1 13 HELIX 10 10 SER A 242 VAL A 253 1 12 HELIX 11 11 TYR A 267 GLN A 271 5 5 HELIX 12 12 GLY A 280 ASN A 304 1 25 HELIX 13 13 ARG A 318 ILE A 323 5 6 HELIX 14 14 THR A 367 ALA A 380 1 14 HELIX 15 15 LEU A 387 SER A 400 1 14 HELIX 16 16 ARG A 401 ARG A 404 5 4 HELIX 17 17 GLY A 416 MET A 420 5 5 HELIX 18 18 GLY B 110 LYS B 121 1 12 HELIX 19 19 TRP B 131 ASN B 144 1 14 HELIX 20 20 THR B 173 ILE B 177 5 5 HELIX 21 21 ASP B 178 ASN B 184 1 7 HELIX 22 22 THR B 194 GLY B 207 1 14 HELIX 23 23 ASP B 225 THR B 229 5 5 HELIX 24 24 SER B 230 SER B 242 1 13 HELIX 25 25 SER B 242 VAL B 253 1 12 HELIX 26 26 TYR B 267 GLN B 271 5 5 HELIX 27 27 GLY B 280 ASN B 304 1 25 HELIX 28 28 SER B 317 ALA B 322 1 6 HELIX 29 29 THR B 367 ALA B 380 1 14 HELIX 30 30 LEU B 387 SER B 400 1 14 HELIX 31 31 ARG B 401 ARG B 404 5 4 HELIX 32 32 GLY B 416 MET B 420 5 5 SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N ILE A 130 O LEU A 165 SHEET 3 A 7 ILE A 99 ALA A 103 1 N ILE A 102 O ILE A 127 SHEET 4 A 7 ILE A 209 HIS A 214 1 O VAL A 213 N ALA A 103 SHEET 5 A 7 MET A 256 THR A 266 1 O ILE A 263 N HIS A 214 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N THR A 266 SHEET 7 A 7 THR A 410 VAL A 413 1 O ILE A 411 N SER A 311 SHEET 1 B 7 ILE B 161 PRO B 166 0 SHEET 2 B 7 LYS B 125 ILE B 130 1 N ILE B 130 O LEU B 165 SHEET 3 B 7 ILE B 99 ALA B 103 1 N CYS B 100 O LYS B 125 SHEET 4 B 7 ILE B 209 HIS B 214 1 O VAL B 213 N ALA B 103 SHEET 5 B 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 B 7 ARG B 306 ALA B 312 1 O ILE B 310 N SER B 264 SHEET 7 B 7 THR B 410 VAL B 413 1 O ILE B 411 N THR B 309 SITE 1 AC1 30 HOH A 60 HOH A 93 ILE A 105 GLY A 106 SITE 2 AC1 30 GLY A 110 TYR A 111 TRP A 131 PHE A 167 SITE 3 AC1 30 ASP A 168 ALA A 169 SER A 170 SER A 215 SITE 4 AC1 30 LEU A 216 ALA A 217 ASN A 218 LEU A 265 SITE 5 AC1 30 THR A 266 TYR A 267 LYS A 285 ALA A 312 SITE 6 AC1 30 GLY A 313 PRO A 314 LEU A 315 SER A 317 SITE 7 AC1 30 ALA A 319 HOH A 429 HOH A 431 HOH A 488 SITE 8 AC1 30 FT2 A 502 HOH A 552 SITE 1 AC2 9 ALA A 217 ALA A 219 TYR A 267 TYR A 277 SITE 2 AC2 9 PRO A 314 ALA A 319 ILE A 323 ILE A 369 SITE 3 AC2 9 NAD A 501 SITE 1 AC3 29 HOH B 35 ILE B 105 GLY B 106 GLY B 110 SITE 2 AC3 29 TYR B 111 TRP B 131 PHE B 167 ASP B 168 SITE 3 AC3 29 ALA B 169 SER B 170 SER B 215 LEU B 216 SITE 4 AC3 29 ALA B 217 ASN B 218 LEU B 265 THR B 266 SITE 5 AC3 29 TYR B 267 LYS B 285 ALA B 312 GLY B 313 SITE 6 AC3 29 PRO B 314 LEU B 315 SER B 317 ALA B 319 SITE 7 AC3 29 HOH B 431 HOH B 444 HOH B 458 HOH B 469 SITE 8 AC3 29 FT2 B 602 SITE 1 AC4 9 ALA B 217 ALA B 219 TYR B 267 TYR B 277 SITE 2 AC4 9 PRO B 314 ALA B 319 ILE B 323 ILE B 369 SITE 3 AC4 9 NAD B 601 CRYST1 131.107 131.107 82.982 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007627 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007627 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012051 0.00000